Three persistent barriers are preventing patients with obstructive sleep apnea (OSA) from receiving timely diagnosis and ...
Pooled TETON‑1/2 trials met the primary endpoint, demonstrating significantly less 52‑week FVC loss with inhaled treprostinil than placebo. Efficacy signals extended to secondary outcomes, reducing ...
Finding a new use for an approved therapy is always welcome news. Finding a use that improves outcomes for a condition where ...
Baseline QOL is an independent prognostic factor for survival in AML, with global QOL carrying the largest HR, according to ...
Sunil Sharma, MD, discusses the consequences of not diagnosing patients with sleep-disordered breathing during hospital ...
Prolonged referral-to-testing workflows motivate using wearable-derived respiratory surrogates to triage suspected ...
Behavioral health utilization rose 62.6% since 2018 and dominates telehealth; timely outpatient linkage reduces behavioral health ED visits and admissions, yielding about $27.63 PMPM total medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results